These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35143268)

  • 1. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018.
    Pro G; Hayes C; Brown CC; Goree J; Zaller N
    Am J Public Health; 2022 Feb; 112(S1):S66-S76. PubMed ID: 35143268
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/Ethnic and Gender Differences in Associations of Medication-Assisted Therapy and Reduced Opioid Use between Outpatient Treatment Admission and Discharge.
    Pro G; Utter J; Cram J; Baldwin J
    J Psychoactive Drugs; 2020; 52(2):186-194. PubMed ID: 32005084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study.
    Hayes CJ; Raciborski RA; Martin BC; Gordon AJ; Hudson TJ; Brown CC; Pro G; Cucciare MA
    J Subst Use Addict Treat; 2024 Nov; 166():209461. PubMed ID: 39067770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
    Pro G; Utter J; Haberstroh S; Baldwin JA
    Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.
    Miles J; Treitler P; Hermida R; Nyaku AN; Simon K; Gupta S; Crystal S; Samples H
    Drug Alcohol Depend; 2023 Nov; 252():110963. PubMed ID: 37748421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
    Xu KY; Schiff DM; Jones HE; Martin CE; Kelly JC; Bierut LJ; Carter EB; Grucza RA
    J Gen Intern Med; 2023 Dec; 38(16):3499-3508. PubMed ID: 37436568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine in the United States: Motives for abuse, misuse, and diversion.
    Chilcoat HD; Amick HR; Sherwood MR; Dunn KE
    J Subst Abuse Treat; 2019 Sep; 104():148-157. PubMed ID: 31370979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.
    Goedel WC; Shapiro A; Cerdá M; Tsai JW; Hadland SE; Marshall BDL
    JAMA Netw Open; 2020 Apr; 3(4):e203711. PubMed ID: 32320038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
    Patrick SW; Buntin MB; Martin PR; Scott TA; Dupont W; Richards M; Cooper WO
    Subst Abus; 2019; 40(3):356-362. PubMed ID: 29949454
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder.
    Bulgin D; Patrick SW; McElroy T; McNeer E; Dupont WD; Murry VM
    Obstet Gynecol; 2023 Aug; 142(2):339-349. PubMed ID: 37473410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities in Geographic Availability of Buprenorphine.
    Drake C; Nagy D; Meiselbach MK; Zhu JM; Saloner B; Stein BD; Polsky D
    J Addict Med; 2024 May-Jun 01; 18(3):335-338. PubMed ID: 38833558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.
    Cantor J; Griffin BA; Levitan B; Mendon-Plasek SJ; Stein BD; Hunter SB; Ober AJ
    JAMA Netw Open; 2024 Jun; 7(6):e2417545. PubMed ID: 38888921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).
    Peeler M; Gupta M; Melvin P; Bryant AS; Diop H; Iverson R; Callaghan K; Wachman EM; Singh R; Houghton M; Greenfield SF; Schiff DM
    Am J Public Health; 2020 Dec; 110(12):1828-1836. PubMed ID: 33058701
    [No Abstract]   [Full Text] [Related]  

  • 20. Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults.
    Jaffe K; Slat S; Chen L; Macleod C; Bohnert A; Lagisetty P
    J Subst Use Addict Treat; 2024 Aug; 163():209361. PubMed ID: 38703949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.